WALTHAM, MA, Immunitas Therapeutics, a biotechnology company, announced $58M in a Series B funding led by Agent Capital.
Immunitas Therapeutics Scores $58M Series B
WALTHAM, MA, Immunitas Therapeutics, a biotechnology company, announced $58M in a Series B funding led by Agent Capital.
